World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000013371
Date of registration: 07/03/2014
Prospective Registration: No
Primary sponsor: Hyogo college of medicine
Public title: Efficacy of infliximab therapy for arthritis after restorative proctocolectomy in patients with ulcerative colitis
Scientific title: Efficacy of infliximab therapy for arthritis after restorative proctocolectomy in patients with ulcerative colitis - Efficacy of infliximab for arthritis after colectomy in ulcerative colitis
Date of first enrolment: 2013/06/05
Target sample size: 10
Recruitment status: Complete: follow-up complete
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012737
Study type:  Interventional
Study design:  Single arm Non-randomized  
Phase:  Not selected
Countries of recruitment
Japan
Contacts
Name:     Motoi Uchino
Address:  1-1 Mukogawacho Nishinomiya Hyogo Japan Japan
Telephone: 0798-45-6111
Email: uchino2s@hyo-med.ac.jp
Affiliation:  Hyogo college of medicine Inflammatory bowel disease center
Name:     Motoi Uchino
Address:  1-1 Mukogawacho Nishinomiya Hyogo Japan Japan
Telephone: 0798-45-6111
Email: uchino2s@hyo-med.ac.jp
Affiliation:  Hyogo college of medicine Inflammatory bowel disease center
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: Patients with pre-existing malignancy, other infectious disease, heart failure, or infusion reaction for infliximab

Age minimum: 20years-old
Age maximum: 80years-old
Gender: Male and Female
Health Condition(s) or Problem(s) studied
ulcerative colitis
Intervention(s)
infliximab
Primary Outcome(s)
Evaluate the degree of arthritis according to Bath Ankylosing Spndylitis Disease Activity Index (BASDAI) during treatment with infliximab
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Hyogo college of medicine
Secondary Sponsor(s)
Ethics review
Status: YES
Approval date:
Contact:
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history